GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion
HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes.
Drugs
Health
Pharma